Updates from ASH 2019: The Latest in MDS and Secondary AML | Aplastic Anemia & MDS International Foundation

Updates from ASH 2019: The Latest in MDS and Secondary AML

Presenter(s): 
Topic(s): 
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Presentation Date: 
Thursday, April 2, 2020

In this webinar, Dr. Amer Zeidan from Yale Cancer Center discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2019 meeting in Orlando, Florida.

Research findings are explained along with the potential impact of this research on understanding and treating MDS and AML.